AU3255097A - Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitors - Google Patents
Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitorsInfo
- Publication number
- AU3255097A AU3255097A AU32550/97A AU3255097A AU3255097A AU 3255097 A AU3255097 A AU 3255097A AU 32550/97 A AU32550/97 A AU 32550/97A AU 3255097 A AU3255097 A AU 3255097A AU 3255097 A AU3255097 A AU 3255097A
- Authority
- AU
- Australia
- Prior art keywords
- alkoxyadenine
- novel
- cytokine inhibitors
- derivatives acting
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK74596 | 1996-07-05 | ||
DK745/96 | 1996-07-05 | ||
PCT/DK1997/000293 WO1998001459A1 (en) | 1996-07-05 | 1997-07-03 | Novel n-alkoxyadenine derivatives acting as cytokine inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3255097A true AU3255097A (en) | 1998-02-02 |
Family
ID=8097056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU32550/97A Abandoned AU3255097A (en) | 1996-07-05 | 1997-07-03 | Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitors |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3255097A (en) |
WO (1) | WO1998001459A1 (en) |
ZA (1) | ZA975986B (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU44900A (en) * | 1998-01-31 | 2003-01-31 | Glaxo Group Limited | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
GB9813554D0 (en) * | 1998-06-23 | 1998-08-19 | Glaxo Group Ltd | Chemical compounds |
US6495528B1 (en) * | 1998-06-23 | 2002-12-17 | Smithkline Beecham Corporation | 2-(Purin -9-yl)-tetrahydrofuran-3,4-diol derivatives |
GB9813535D0 (en) * | 1998-06-23 | 1998-08-19 | Glaxo Group Ltd | Chemical compounds |
GB9813540D0 (en) * | 1998-06-23 | 1998-08-19 | Glaxo Group Ltd | Chemical compounds |
AU2002323990B2 (en) * | 1998-06-23 | 2006-03-30 | Glaxo Group Limited | Adenosine derivatives |
GB9813565D0 (en) * | 1998-06-23 | 1998-08-19 | Glaxo Group Ltd | Chemical compounds |
WO2001002400A1 (en) | 1999-07-02 | 2001-01-11 | Eisai Co., Ltd. | Fused imidazole compounds and remedies for diabetes mellitus |
GB0022695D0 (en) | 2000-09-15 | 2000-11-01 | Pfizer Ltd | Purine Derivatives |
GB0106867D0 (en) | 2001-03-20 | 2001-05-09 | Glaxo Group Ltd | Process |
AU2002951247A0 (en) | 2002-09-06 | 2002-09-19 | Alchemia Limited | Compounds that interact with kinases |
JP2006516641A (en) * | 2003-02-03 | 2006-07-06 | シーブイ・セラピューティクス・インコーポレイテッド | Full and partial agonists of adenosine receptors |
PE20060272A1 (en) | 2004-05-24 | 2006-05-22 | Glaxo Group Ltd | (2R, 3R, 4S, 5R, 2'R, 3'R, 4'S, 5'S) -2.2 '- {TRANS-1,4-CYCLOHEXANODIYLBIS- [IMINO (2 - {[2- (1-METHYL- 1H-IMIDAZOL-4-IL) ETHYL] AMINO} -9H-PURIN-6,9-DIYL)]} BIS [5- (2-ETHYL-2H-TETRAZOLE-5-IL) TETRAHYDRO-3,4-FURANODIOL] AS AN A2A AGONIST |
GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
WO2013120078A1 (en) | 2012-02-11 | 2013-08-15 | Academia Sinica | Methods and compositions for treating pain |
CN108676048B (en) * | 2018-06-04 | 2021-04-27 | 上海兆维科技发展有限公司 | Preparation method of cordycepin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4962194A (en) * | 1987-04-02 | 1990-10-09 | Warner-Lambert Company | Method of preparing 51,N6-disubstituted adenosines from inosines |
IL108523A0 (en) * | 1993-02-03 | 1994-05-30 | Gensia Inc | Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain |
-
1997
- 1997-07-03 AU AU32550/97A patent/AU3255097A/en not_active Abandoned
- 1997-07-03 WO PCT/DK1997/000293 patent/WO1998001459A1/en active Search and Examination
- 1997-07-04 ZA ZA9705986A patent/ZA975986B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1998001459A1 (en) | 1998-01-15 |
ZA975986B (en) | 1998-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4791797A (en) | 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors | |
AU1301697A (en) | Tyrosin-derivate as alpha-v-integrin inhibitors | |
AU4383397A (en) | Hetaroyl derivatives | |
AU3343097A (en) | Phenylalamine derivatives as integrin inhibitors | |
AU4554297A (en) | Hetaroyl derivatives | |
AU5135998A (en) | Novel urea derivatives | |
AUPO395396A0 (en) | Benzamide derivatives | |
AU1735497A (en) | Sulfonylureidopyrazole derivatives | |
AU1594697A (en) | New substituted 19-nor-pregnane derivatives | |
AU7738098A (en) | Novel tetrahydrobenzindolone derivatives | |
AU3867997A (en) | Chromene-3-carboxylate derivatives | |
AU3255097A (en) | Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitors | |
AU2956097A (en) | Alkylaminobenzothiazole and -benzoxazole derivatives | |
AU5652698A (en) | (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors | |
EP1008579A3 (en) | Cyclopentenebutanol derivatives | |
AU1605699A (en) | Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors (ii) | |
AU3827897A (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
AU2961097A (en) | Substituted pyrazolylpyrazole derivatives | |
AU4962097A (en) | 2-methoxyphenylpiperazine derivatives | |
AU4622597A (en) | Novel pyranoside derivatives | |
AU1793197A (en) | Pyrazole-4-yl-hetaroyl derivatives | |
AUPO863197A0 (en) | Novel derivatives | |
AU6994396A (en) | Substituted indolylpropyl-piperazine derivatives as 5-ht1dalpha agonists | |
AU3685097A (en) | N-benzylazolium derivatives | |
AU3906997A (en) | Novel heterocycle compositions |